- Filed
- Apr 22, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Apr 15, 2026 | 69.7M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 70M sh |
| Shares Diluted restated | Q1 2026 · Mar 31, 2025 | 74M sh |
| Stock Repurchased | Q1 2026 · Mar 31, 2026 | $0 |
| Stock Repurchased restated | Q1 2026 · Mar 31, 2025 | $87M |
| Dividends Paid | Q1 2026 · Mar 31, 2026 | $31M |
| Dividends Paid restated | Q1 2026 · Mar 31, 2025 | $31M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | $295M |
| Operating Cash Flow restated | Q1 2026 · Mar 31, 2025 | $247M |
| Long Term Debt | Q1 2026 · Mar 31, 2026 | $4.87B |
| Long Term Debt | Q1 2026 · Dec 31, 2025 | $5.07B |
| Short Term Debt | Q1 2026 · Mar 31, 2026 | $63M |
| Short Term Debt | Q1 2026 · Dec 31, 2025 | $63M |
| Cash And Equivalents | Q1 2026 · Mar 31, 2026 | $200M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $201M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $1.1B |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $1.01B |
| Stockholders Equity restated | Q1 2026 · Mar 31, 2025 | $1.07B |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | $1.08B |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $836M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $733M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $6.34B |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $6.43B |
| Current Assets | Q1 2026 · Mar 31, 2026 | $452M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $443M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $7.49B |
| Total Assets | Q1 2026 · Dec 31, 2025 | $7.49B |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $59M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $55M |
| Net Income | Q1 2026 · Mar 31, 2026 | $83M |
| Net Income restated | Q1 2026 · Mar 31, 2025 | $77M |
| Operating Income | Q1 2026 · Mar 31, 2026 | $143M |
| Operating Income restated | Q1 2026 · Mar 31, 2025 | $135M |
| Revenue | Q1 2026 · Mar 31, 2026 | $663M |
| Revenue restated | Q1 2026 · Mar 31, 2025 | $643M |